Century Therapeutics, Inc. (IPSC): Shareholders' Equity
$158.94M
As of 2025-12-31
$232.34M
As of 2026-06-30
-19.3%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $158.94M | -1.5% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $161.36M | -12.7% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $184.75M | -39.0% | 2025-03-19, Balance as of period end |
| 2022-12-31 | $302.74M | -23.6% | 2024-03-14, Balance as of period end |
| 2021-12-31 | $396.24M | n/m | 2023-03-16, Balance as of period end |
| 2020-12-31 | -$106.41M | n/a | 2022-03-17, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | 2025-12-31 | $158.94M | -1.5% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | -$500.47M | n/m |
| Agenus Inc (AGEN) | 2025-12-31 | -$271.11M | n/m |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | -$132.45M | n/m |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | -$38.50M | n/m |
| Monte Rosa Therapeutics, Inc. (GLUE) | 2025-12-31 | $233.06M | +4.5% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $1.24B | +68.8% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $505.66M | -1.0% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | -$5.79M | n/m |
Compare IPSC, IBRX, AGEN, STRO side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗